NewGenIvf Files F-1 Amendment for $10M Best-Efforts Offering and 3.56M Share Resale
NIVF sits 17% above its 52-week low of $1.154 on light trading volume (0.1× avg).
Summary
NewGenIvf filed an F-1 amendment for a $10M best-efforts offering and resale of 3.56M shares by noteholders, revealing $9.3M in convertible debt and $6.5M in unpaid K25.ai obligations.
Key Events · Financing and Capital Events · NIVF
-
Best-Efforts Offering Registered
Amendment No. 1 registers an indeterminate number of Class A Ordinary Shares and Pre-Funded Warrants with estimated gross proceeds of $10 million and net proceeds of $9 million after placement agent fees and expenses.
-
Selling Securityholder Resale
Up to 3,555,900 Class A Ordinary Shares are registered for resale by Vanquish Funding Group, White Lion Capital, and Pacific Pier Capital, representing potential conversion of outstanding convertible notes at a 25% discount to market.
-
Liquidity Pressure Disclosed
As of August 19, 2026, the company had $9,305,580.75 in outstanding convertible promissory notes and $6,462,500 in unpaid K25.ai equity investment obligations, with only $758,621 in cash as of December 31, 2025.
-
White Lion Equity Line Utilization
Approximately $18.92 million has been drawn from the $100 million White Lion Capital equity line of credit, resulting in significant ongoing dilution to existing shareholders.
Analysis · NIVF · Industrial Applications And Services
NewGenIvf Group filed Amendment No. 1 to its F-1 registration statement, registering a best-efforts offering of Class A Ordinary Shares and Pre-Funded Warrants with estimated gross proceeds of $10 million, alongside the resale of up to 3,555,900 shares by three Selling Securityholders. The offering is highly dilutive for a company with a market cap of approximately $8.6 million, and the resale registration creates a significant overhang. The filing also discloses $9.3 million in outstanding convertible notes and $6.5 million in unpaid K25.ai investment obligations, underscoring acute liquidity pressure. The company has drawn $18.92 million from its White Lion equity line, further diluting existing holders. This capital raise is critical for survival but comes at a steep cost to current shareholders.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NIVF was trading at $1.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.6M. The 52-week trading range was $1.15 to $1,539.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.